Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Strata Critical Medical (SRTA) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Strata Critical Medical's Share-based Compensation fell 6890.04% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year decrease of 1483.8%. This contributed to the annual value of $19.9 million for FY2024, which is 5913.13% up from last year.
  • Latest data reveals that Strata Critical Medical reported Share-based Compensation of $1.7 million as of Q3 2025, which was down 6890.04% from $5.3 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Share-based Compensation registered a high of $8.3 million during Q3 2021, and its lowest value of $1.7 million during Q3 2025.
  • Its 5-year average for Share-based Compensation is $3.9 million, with a median of $3.6 million in 2022.
  • In the last 5 years, Strata Critical Medical's Share-based Compensation soared by 365945.95% in 2021 and then tumbled by 6890.04% in 2025.
  • Strata Critical Medical's Share-based Compensation (Quarter) stood at $2.9 million in 2021, then dropped by 9.59% to $2.6 million in 2022, then rose by 18.98% to $3.2 million in 2023, then surged by 43.55% to $4.5 million in 2024, then tumbled by 62.88% to $1.7 million in 2025.
  • Its Share-based Compensation was $1.7 million in Q3 2025, compared to $5.3 million in Q2 2025 and $4.2 million in Q1 2025.